Atlas Trials

Trial of pIL-12 Electroporation Malignant Melanoma

Clinical trial NCT01502293 · COMPLETED

Trial details

NCT number
NCT01502293
Sponsor
OncoSec Medical Incorporated
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2012-02-14
Primary completion
2016-03-21
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.